Publication | Closed Access

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

AsthmaRheumatologyAllergyAllergy MedicinePharmacologyClinical TrialsPlacebo-controlled TrialsLavolta IiPharmacotherapyPharmacologic InterventionMedicineClinical AllergyPhase 3